Evidence map›Paper›PMID 32190073›Full record

ReviewJournal of contemporary brachytherapy2020

The role of brachytherapy in the management of brain metastases: a systematic review.

Bhargava Chitti, Sharad Goyal, Jonathan H Sherman, Anthony Caputy, Mehrdad Sarfaraz, Gizem Cifter, Hamid Aghdam, Yuan James Rao

Open access · goldAbstract readReview
In one paragraph

Review in Journal of contemporary brachytherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Update on the Management of Brain Metastasis.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Bhargava ChittiRadiation Oncology, George Washington University School of Medicine and Health Sciences, United States.
Sharad GoyalRadiation Oncology, George Washington University School of Medicine and Health Sciences, United States.
Jonathan H ShermanNeurosurgery, George Washington University School of Medicine and Health Sciences, United States.
Anthony CaputyNeurosurgery, George Washington University School of Medicine and Health Sciences, United States.
Mehrdad SarfarazRadiation Oncology, George Washington University School of Medicine and Health Sciences, United States.
Gizem CifterRadiation Oncology, George Washington University School of Medicine and Health Sciences, United States.
Hamid AghdamRadiation Oncology, George Washington University School of Medicine and Health Sciences, United States.
Yuan James RaoRadiation Oncology, George Washington University School of Medicine and Health Sciences, United States.
George Washington University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeBrain metastases have a highly variable prognosis depending on the primary tumor and associated prognostic factors. Standard of care for patients with these tumors includes craniotomy, stereotactic radiosurgery (SRS), or whole brain radiotherapy (WBRT) for patients with brain metastases. Brachytherapy shows great promise as a therapy for brain metastases, but its role has not been sufficiently explored in the current literature. MATERIAL AND

methodsThe PubMed, Cochrane, and Scopus databases were searched using a combination of search terms and synonyms for brachytherapy, brain neoplasms, and brain metastases, for articles published between January 1

resultsMost data focused on

conclusionsFor a variety of reasons including absence of physician expertise in brachytherapy, lack of published data on treatment outcomes, and rates of radiation necrosis, brachytherapy is not presently a part of standard paradigm for brain metastases. However, our review indicates brachytherapy as a modality that offers excellent local control and quality of life, and suggested that its use should be further studied.

Indexed as

brachytherapybrain metastasesradiation therapy

Identifiers

PMID32190073
PMCPMC7073344
OpenAlexW3012644521

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.